The relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients

Semahat Karahisar Şirali; Refika Büberci

Makale detayları

The relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients

Yazarlar:

Semahat Karahisar Şirali | Refika Büberci

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Nefroloji

Dergi:

The European Research Journal Vol.10 Issue 3, pp.311-318

Belge Tipi:

Makale

Yayın Tarihi:

4/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001315670

pISSN:

2149-3189

Anahtar kelimeler:

Özet:

 Objectives: Diagnosing fibromyalgia, a condition characterized by widespread body pain of unknown origin accompanied by various additional symptoms, poses a challenge in hemodialysis patients, who frequently experience musculoskeletal disorders. To investigate the relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients. Methods: The study enrolled 311 hemodialysis patients undergoing treatment for over three months. Demographic characteristics, complete blood count, and biochemical values were documented as part of the study. To assess fibromyalgia, the researchers recorded the patients scores on the Generalized Pain Scale and Symptom Severity Scale based on data provided by the American College of Rheumatology. The patients were then divided into two groups: those with fibromyalgia and those without fibromyalgia, and their laboratory values and rates were compared. Inflammatory parameters such as erythrocyte sedimentation rate, c reactive protein, monocyte-to-lymphocyte ratio, lymphocyte-to-c reactive protein ratio, and c reactive protein to albumin ratio were recorded. Results: The study included 311 patients on hemodialysis for more than three months. Among the study participants, 48.9 of the patients and 62.9 of those with fibromyalgia were women. The mean age was 5426 years and was significantly higher in patients with fibromyalgia P0.001. Monocyte P0.03, C-reactive protein P0.01, erythrocyte sedimentation rate P0.02, Monocyte to lymphocyte ratio P0.028, c reactive protein to albumin ratio P0.005 were significantly higher, lymphocyte to c reactive protein ratio P0.004 and albumin P0.018 were significantly lower in the fibromyalgia group. Conclusions: Fibromyalgia should be considered in the presence of high inflammation parameters in hemodialysis patients with diffuse musculoskeletal pain.

 Objectives: Diagnosing fibromyalgia, a condition characterized by widespread body pain of unknown origin accompanied by various additional symptoms, poses a challenge in hemodialysis patients, who frequently experience musculoskeletal disorders. To investigate the relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients. Methods: The study enrolled 311 hemodialysis patients undergoing treatment for over three months. Demographic characteristics, complete blood count, and biochemical values were documented as part of the study. To assess fibromyalgia, the researchers recorded the patients scores on the Generalized Pain Scale and Symptom Severity Scale based on data provided by the American College of Rheumatology. The patients were then divided into two groups: those with fibromyalgia and those without fibromyalgia, and their laboratory values and rates were compared. Inflammatory parameters such as erythrocyte sedimentation rate, c reactive protein, monocyte-to-lymphocyte ratio, lymphocyte-to-c reactive protein ratio, and c reactive protein to albumin ratio were recorded. Results: The study included 311 patients on hemodialysis for more than three months. Among the study participants, 48.9 of the patients and 62.9 of those with fibromyalgia were women. The mean age was 5426 years and was significantly higher in patients with fibromyalgia P0.001. Monocyte P0.03, C-reactive protein P0.01, erythrocyte sedimentation rate P0.02, Monocyte to lymphocyte ratio P0.028, c reactive protein to albumin ratio P0.005 were significantly higher, lymphocyte to c reactive protein ratio P0.004 and albumin P0.018 were significantly lower in the fibromyalgia group. Conclusions: Fibromyalgia should be considered in the presence of high inflammation parameters in hemodialysis patients with diffuse musculoskeletal pain.

 Objectives: Diagnosing fibromyalgia, a condition characterized by widespread body pain of unknown origin accompanied by various additional symptoms, poses a challenge in hemodialysis patients, who frequently experience musculoskeletal disorders. To investigate the relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients. Methods: The study enrolled 311 hemodialysis patients undergoing treatment for over three months. Demographic characteristics, complete blood count, and biochemical values were documented as part of the study. To assess fibromyalgia, the researchers recorded the patients scores on the Generalized Pain Scale and Symptom Severity Scale based on data provided by the American College of Rheumatology. The patients were then divided into two groups: those with fibromyalgia and those without fibromyalgia, and their laboratory values and rates were compared. Inflammatory parameters such as erythrocyte sedimentation rate, c reactive protein, monocyte-to-lymphocyte ratio, lymphocyte-to-c reactive protein ratio, and c reactive protein to albumin ratio were recorded. Results: The study included 311 patients on hemodialysis for more than three months. Among the study participants, 48.9 of the patients and 62.9 of those with fibromyalgia were women. The mean age was 5426 years and was significantly higher in patients with fibromyalgia P0.001. Monocyte P0.03, C-reactive protein P0.01, erythrocyte sedimentation rate P0.02, Monocyte to lymphocyte ratio P0.028, c reactive protein to albumin ratio P0.005 were significantly higher, lymphocyte to c reactive protein ratio P0.004 and albumin P0.018 were significantly lower in the fibromyalgia group. Conclusions: Fibromyalgia should be considered in the presence of high inflammation parameters in hemodialysis patients with diffuse musculoskeletal pain.

 Objectives: Diagnosing fibromyalgia, a condition characterized by widespread body pain of unknown origin accompanied by various additional symptoms, poses a challenge in hemodialysis patients, who frequently experience musculoskeletal disorders. To investigate the relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients. Methods: The study enrolled 311 hemodialysis patients undergoing treatment for over three months. Demographic characteristics, complete blood count, and biochemical values were documented as part of the study. To assess fibromyalgia, the researchers recorded the patients scores on the Generalized Pain Scale and Symptom Severity Scale based on data provided by the American College of Rheumatology. The patients were then divided into two groups: those with fibromyalgia and those without fibromyalgia, and their laboratory values and rates were compared. Inflammatory parameters such as erythrocyte sedimentation rate, c reactive protein, monocyte-to-lymphocyte ratio, lymphocyte-to-c reactive protein ratio, and c reactive protein to albumin ratio were recorded. Results: The study included 311 patients on hemodialysis for more than three months. Among the study participants, 48.9 of the patients and 62.9 of those with fibromyalgia were women. The mean age was 5426 years and was significantly higher in patients with fibromyalgia P0.001. Monocyte P0.03, C-reactive protein P0.01, erythrocyte sedimentation rate P0.02, Monocyte to lymphocyte ratio P0.028, c reactive protein to albumin ratio P0.005 were significantly higher, lymphocyte to c reactive protein ratio P0.004 and albumin P0.018 were significantly lower in the fibromyalgia group. Conclusions: Fibromyalgia should be considered in the presence of high inflammation parameters in hemodialysis patients with diffuse musculoskeletal pain.

Makale detayları

The relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients

Yazarlar:

Semahat Karahisar Şirali | Refika Büberci

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Nefroloji

Dergi:

The European Research Journal Vol.10 Issue 3, pp.311-318

Belge Tipi:

Makale

Yayın Tarihi:

4/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001315670

pISSN:

2149-3189

Fibromyalgia

hemodialysis

inflammation parameters

hematological indices

Sayı

Makale detayları

The relationship between fibromyalgia syndrome and inflammation parameters in hemodialysis patients

Yazarlar: Semahat Karahisar Şirali | Refika Büberci

Yayıncı: Prusa Medical Publishing

Ana Başlıklar: Nefroloji

Dergi: The European Research Journal Vol.10 Issue 3, pp.311-318

Belge Tipi: Makale

Yayın Tarihi: 4/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001315670

pISSN: 2149-3189

Fibromyalgia

hemodialysis

inflammation parameters

hematological indices

Sayı

Yazarlar:

Semahat Karahisar Şirali | Refika Büberci

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Nefroloji

Dergi:

The European Research Journal Vol.10 Issue 3, pp.311-318

Belge Tipi:

Makale

Yayın Tarihi:

4/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001315670

pISSN:

2149-3189